scholarly article | Q13442814 |
P50 | author | Michael W Kattan | Q60653077 |
P2093 | author name string | Brian J Wells | |
Alex Milinovich | |||
Jonathan Bouchard | |||
Changhong Yu | |||
Robert S Zimmerman | |||
Brian Sakurada | |||
Sheldon X Kong | |||
Wayne Weng | |||
Kevin M Pantalone | |||
Todd M Hobbs | |||
Janine M Bauman | |||
P2860 | cites work | Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 |
Standards of medical care in diabetes--2014 | Q28304435 | ||
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Q29619886 | ||
Prevalence of diabetic retinopathy in the United States, 2005-2008. | Q34154127 | ||
Standards of medical care in diabetes--2011. | Q34425055 | ||
Centers for Disease Control and Prevention. State indicator report on Physical Activity, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014 | Q34471904 | ||
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. | Q34628009 | ||
Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study | Q35751198 | ||
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study | Q36001145 | ||
The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. | Q37022665 | ||
Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization | Q37260160 | ||
Nephropathy in diabetes | Q44705106 | ||
Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. | Q46046433 | ||
Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes | Q46401219 | ||
Achievement of goals in U.S. diabetes care, 1999-2010. | Q51045064 | ||
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis | Q63966646 | ||
Changes in diabetes-related complications in the United States, 1990-2010 | Q64125961 | ||
Integrated delivery systems: the cure for fragmentation | Q82582723 | ||
P433 | issue | 1 | |
P921 | main subject | comorbidity | Q1414874 |
type 2 diabetes | Q3025883 | ||
P304 | page(s) | e000093 | |
P577 | publication date | 2015-07-22 | |
P1433 | published in | BMJ open diabetes research & care | Q27725999 |
P1476 | title | Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system | |
P478 | volume | 3 |
Q38796894 | Biomechanisms of Comorbidity: Reviewing Integrative Analyses of Multi-omics Datasets and Electronic Health Records |
Q64105044 | Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans |
Q57164680 | Continuous Glucose Monitoring: Current Use in Diabetes Management and Possible Future Applications |
Q47636753 | Correlation of Electrophotonic Imaging Parameters With Fasting Blood Sugar in Normal, Prediabetic, and Diabetic Study Participants |
Q57294147 | Diabetes and the direct secondary use of electronic health records: Using routinely collected and stored data to drive research and understanding |
Q49833824 | Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms |
Q38994655 | Dynamics of diabetes and obesity: Epidemiological perspective |
Q64938193 | Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies. |
Q92892527 | Eugenia jambolana extract reduces the systemic exposure of Sitagliptin and improves conditions associated with diabetes: A pharmacokinetic and a pharmacodynamic herb-drug interaction study |
Q55646317 | Evaluation of a Diabetes Self-Management Program: Claims Analysis on Comorbid Illnesses, Health Care Utilization, and Cost. |
Q64068724 | Exploring the relationship between coronary heart disease and type 2 diabetes: a cross-sectional study of secondary prevention among diabetes patients |
Q93016948 | From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research |
Q28080114 | Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure |
Q92307608 | Indicators of Quality of Clinical Care for Type 2 Diabetes Patients in Primary Health Care Centers in Qatar: A Retrospective Analysis |
Q51213030 | Levels of heavy metals and their binding protein metallothionein in type 2 diabetics with kidney disease. |
Q38865936 | Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss. |
Q38912660 | Neuropsychiatric comorbidities in adults with phenylketonuria: A retrospective cohort study |
Q36106099 | Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data |
Q64075400 | Predictors of poor glycemic control among patients with type 2 diabetes on follow-up care at a tertiary healthcare setting in Ethiopia |
Q47329557 | Prevalence and co-prevalence of comorbidities in Belgian patients with type 2 diabetes mellitus: a transversal, descriptive study |
Q91583309 | Relationships Between Neurodegeneration and Vascular Damage in Diabetic Retinopathy |
Q91759548 | SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice |
Q55035609 | The management of diabetic ketoacidosis at a rural regional hospital in KwaZulu-Natal. |
Q91787194 | The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States |
Q93128624 | The role of blood volume in cardiac dysfunction and reduced exercise tolerance in patients with diabetes |
Q47103092 | Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional Analysis. |
Q90345914 | Transplantation of IL-10-Overexpressing Bone Marrow-Derived Mesenchymal Stem Cells Ameliorates Diabetic-Induced Impaired Fracture Healing in Mice |
Q47150840 | Type 2 diabetes in general practice in Norway 2005-2014: moderate improvements in risk factor control but still major gaps in complication screening |
Q64105782 | Validation of Two Automatic Blood Pressure Monitors With the Ability to Transfer Data via Bluetooth |
Q90402294 | [Primary Prevention of Acute Stroke] |